Loading...
Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update
Hematopoietic cell transplant (HCT) can cure both children and adults with sickle cell disease. Outcomes have historically been poor for the vast majority of patients who lack a matched sibling donor. However, the development of haploidentical HCT (haplo-HCT) with high doses of posttransplant cyclop...
Na minha lista:
| Udgivet i: | Hematol Oncol Stem Cell Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
King Faisal Specialist Hospital & Research Centre. Published by Elsevier Ltd.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118612/ https://ncbi.nlm.nih.gov/pubmed/32202252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hemonc.2020.01.002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|